21 C.F.R. § 20.83

Disclosure required by court order

Read at: eCFRecfr.gov CornellLII GovInfogovinfo.gov CasesGoogle Scholar

(a) Records of the Food and Drug Administration which the Commissioner has determined are not available for public disclosure, in the form of a regulation published or cross-referenced in this part, shall nevertheless be made available for public disclosure in compliance with a final court order requiring such disclosure.

(b) Where the Food and Drug Administration record ordered disclosed under paragraph (a) of this section is a record about an individual that is not available for public disclosure under § 20.63, the Food and Drug Administration shall attempt to notify the individual who is the subject of the record of the disclosure, by sending a notice to the individual's last known address.

(c) Paragraph (b) of this section shall not apply where the name or other personal identifying information is deleted prior to disclosure.

[42 FR 15616, Mar. 22, 1977, as amended at 68 FR 25287, May 12, 2003]
Notes of Decisions
Cited in 3 cases, 1993–2015 · leading case: Eli Lilly & Co. v. Marshall, 850 S.W.2d 155 (Tex. 1993).
Eli Lilly & Co. v. Marshall, 850 S.W.2d 155 (Tex. 1993). · cites it 10× “While the need for confidentiality as determined by the FDA, and as promised on form 1639 and expressed in the regulations, may yield to a proper court order under 21 C.F.R. § 20.83 (a), here the trial court ordered full disclosure without according any weight to the public…”
in Re Benevis, LLC, Dentistry of Brownsville, P.C., & Kool Smiles, P.C. (Tex. App. 2015). · cites it 4× “expressed in the regulations, may yield to a proper court order under 21 C.F.R. § 20.83 (a), here the trial court ordered full disclosure without according any weight to the public © 2015 Thomson Reuters.”
Joann Mostovoy & Vadim Mostovoy, in Their Own Right & as Best Friends of Their Son, Vjm v. Sec'y of Health & Human Servs. (Fed. Cl. 2013). “21 C.F.R. § 20.83 (a). Any order issued by this court would be unlikely to compromise the protection accorded to confidential business information and thus, would allow FDA to redact the produced documents.”
— 21 C.F.R. § 20.83(a) — 2 cases
Eli Lilly & Co. v. Marshall, 850 S.W.2d 155 (Tex. 1993). “While the need for confidentiality as determined by the FDA, and as promised on form 1639 and expressed in the regulations, may yield to a proper court order under 21 C.F.R. § 20.83 (a), here the trial court ordered full disclosure without according any weight to the public…”
in Re Benevis, LLC, Dentistry of Brownsville, P.C., & Kool Smiles, P.C. (Tex. App. 2015). “expressed in the regulations, may yield to a proper court order under 21 C.F.R. § 20.83 (a), here the trial court ordered full disclosure without according any weight to the public © 2015 Thomson Reuters.”
Annotations are extracted automatically from the opinions in the Syfert caselaw corpus and ranked by authority, recency, and treatment. Dots show Syfertize treatment of the citing case itself.